Skip to main content

Table 4 Correlation of time from illness onset to hospitalization with systemic inflammation and features of organ dysfunction

From: Differences in the clinical characteristics and outcomes of COVID-19 patients in the epicenter and peripheral areas of the pandemic from China: a retrospective, large-sample, comparative analysis

Variables

Model 1

Model 2

Model 3

Model 4

r

P value

r

P value

r

P value

r

P value

White blood cell count, ×109/L

0.086

0.004

0.081

0.007

0.082

0.007

0.080

0.008

Neutrophil count, × 109/L

0.089

0.003

0.061

0.044

0.064

0.035

0.061

0.046

Lymphocyte count, ×109/L

−0.026

0.391

0.027

0.380

0.025

0.414

0.032

0.293

Eosinophil count, ×109/L

0.116

< 0.001

0.119

< 0.001

0.118

< 0.001

0.127

< 0.001

Hemoglobin, g/L

−0.155

< 0.001

− 0.100

0.001

−0.104

0.001

−0.103

0.001

Platelet count, × 109 /L

0.212

< 0.001

0.225

< 0.001

0.223

< 0.001

0.225

< 0.001

BUN, mmol/L

0.100

0.002

0.038

0.247

0.040

0.215

0.039

0.226

Creatinine, μmol/L

−0.094

0.003

−0.117

< 0.001

−0.141

< 0.001

−0.141

< 0.001

Creatine kinase, U/L

−0.155

< 0.001

−0.145

< 0.001

−0.165

< 0.001

−0.166

< 0.001

Albumin, g/L

−0.263

< 0.001

−0.200

< 0.001

−0.194

< 0.001

−0.192

< 0.001

APTT, s

−0.247

< 0.001

−0.216

< 0.001

−0.212

< 0.001

−0.212

< 0.001

PT, s

−0.018

0.600

−0.019

0.567

−0.021

0.537

−0.021

0.535

D-dimer, mg/L

0.101

0.004

0.043

0.210

0.047

0.175

0.046

0.182

C-reactive protein, mg/L

0.051

0.210

0.021

0.619

0.017

0.674

0.014

0.731

Procalcitonin, ng/mL

−0.093

0.019

−0.123

0.002

−0.130

0.001

−0.135

0.001

IL-6, pg/mL

−0.094

0.407

−0.155

0.171

−0.144

0.211

−0.144

0.215

  1. Model 1: Unadjusted; Model 2: Adjusted for age; Model 3: Adjusted for age, sex, smoking; Model 4: Adjusted for age, sex, smoking, and use steroid use
  2. APTT Activated partial thromboplastin time, PT Prothrombin time, BUN Blood urea nitrogen